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ABSTRACT 
Silica aerogel (SA) was loaded with domperidone to demonstrate the potentiality of adsorption processes based on the 
usage of supercritical carbon dioxide to treat poorly water-soluble drugs, forming new kinds of drug delivery systems. 
The effects of pressure, temperature and solution concentration on loaded SA were studied. Adsorption isotherms were 
measured at 35˚C and 45˚C and fitted with Langmuir model. Release kinetics of the adsorbed drug were also evaluated 
by in vitro dissolution tests. Results showed that domperidone can be uniformly dispersed into the aerogel and that the 
release rate of domperidone from the composite, constituted by drug and silica aerogel, is much faster than that of the 
crystalline drug. The proposed adsorption method is suitable for the production of domperidone fast release tablets. 
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1. Introduction 
The poor water solubility of some drugs limited their 
bioavailability. A fast dissolving system can be defined 
as a dosage form for oral administration, which when 
placed in mouth, rapidly dispersed or dissolved increas- 
ing compliance and efficacy of the therapy. Fast dissolv- 
ing and fast dispersing drug delivery system may offer a 
solution to these problems [1]. Domperidone (DMP), a 
dopamine antagonist, is widely used in the treatment of 
nausea and vomiting in the dose range of 10 - 40 mg/day. 
It has a low water solubility at low pH that limits its bio- 
availability in the gastric fluid. When given as an imme- 
diate release tablet, its onset of action is after half an 
hour and the drug effect lasts for 4 - 7 h [2]. DMP has an 
even more reduced solubility in alkaline pH. Because 
oral dosage forms are exposed to an environment of in- 
creasing pH, the poorly soluble DMP molecules may get 
precipitated in the intestinal fluid resulting in low DMP 
bioavailability (<15%) which therefore, may not mini- 
mize the rate of vomiting [1,2]. A possible approach for 
ensuring maximum bioavailability in the intestinal fluid 
is the increase of DMP solubility after adsorption at mo- 
lecular level on a proper host matrix. 
To improve the dissolution rate of drugs, different 
techniques have been developed [3]. The most common 
approach is based on particle size reduction that can be 
achieved by processes based on micronization or nano- 
suspension. Each technique utilizes different equipment 
for the reduction of the particle size [4,5]. In the field of 
supercritical fluids, various promising techniques of mi- 
cronization of drugs and excipients with SC-CO2 have 
been developed [6-8] and also the use of the less expen- 
sive SC-N2 is being explored [9]. An alternative way to 
improve the availability of a drug is its dispersion on a 
biocompatible substrate [10]. Silica based materials used 
as substrate are widely employed as additives, free flow 
agents and drug carriers also in commercial products. A 
special class of silica materials is silica aerogels (SA). 
They are low density nano-porous solids with a fine 
openpore structure that exhibit unique properties, such as 
high porosity (90% - 99%), high surface area (400 - 1000 
m2/g), extremely low density (0.003 - 0.15 g/cm3). These 
properties allow them to be used as a host matrix for drug 
delivery. Silica aerogels were recently shown to be a 
potential candidate for oral drug delivery systems [11-13]. 
A promising method to adsorb a drug into porous sub- 
strates is supercritical (SC) deposition or adsorption [11, 
12,14-16]. Essentially, the process involves the dissolu- 
tion of the active molecules in a supercritical fluid and 
the impregnation of the substrate by its exposure to this 
solution. Supercritical carbon dioxide (SC-CO2) is com- 
monly used due to its relatively good solvent power for 
various drugs, mild critical temperature (31˚C), low 
critical pressure (7.4 MPa) and inertness. After the remo- 
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val of the SCF by expansion, a drug-loaded matrix free 
of solvent residues is obtained. This method takes ad- 
vantage of the unique properties of SCFs. Indeed, a SCF 
possesses a unique combination of gas-like and liquid- 
like properties, which can be adjusted by small changes 
in temperature or pressure. 
Low viscosity and high diffusivity of SC-CO2 allows a 
rapid equilibration and micropore penetration of the fluid 
phase within the matrix. SCFs also have zero surface 
tension that not only facilitates the rapid permeation and 
diffusion into porous substrates, but also avoids the pore 
collapse of SA that occurs using organic liquids, due to 
capillary stresses caused by the liquid-vapor menisci 
within pores.  
In this work, the adsorption of domperidone on SA 
was studied at various conditions of temperature and 
concentration. The experimental work basically consisted 
in 1) study of the solubility of DMP in SC-CO2 to know 
the saturation conditions as a function of temperature and 
pressure; 2) study of adsorption isotherms to know the 
relationship between concentration of DMP in the fluid 
phase and in the solid phase at equilibrium; 3) in vitro 
drug release tests to study the properties of the composite 
material and its potentiality for industrial applications. 
2. Experimental 
2.1. Materials 
Hydrophilic silica aerogel (SA) in form of monolithic 
blocks was purchased from Merketech Int. (USA). The 
nominal density is 0.1 g/cm3 and the surface area is 800 
m2/g and the mean pore size is about 20 nm. Deposition 
experiments were performed using cubic blocks of 1 cm 
obtained by cutting SA monoliths with a knife. CO2 re-
search grade 4.8 was purchased from SON (Italy). All 
products were used as received. Domperidone (purity 
98%) was kindly donated by Italchimicis. p.a. (Pomezia, 
Italy). 
2.2. Solubility Measurements 
The solubility of nimesulide in SC-CO2 was determined 
experimentally at 45˚C in the pressure range 10.0 - 18.0 
MPa using a static synthetic method [17]. A variable 
volume view cell was used for measurements (Figure 1). 
The cell is equipped with anair-driven piston (A) that 
allows to smoothly change the internal volume from 32 
to 61 cm3. One front and one back sapphire windows 
allow to look inside the cell. An optical microscope 
(Nikon SMZ800, 6× mag.) allows to inspectsolubiliza- 
tion of small crystals. The cell is heated by electric car- 
tridges (Watlow, USA) whose thermal control is guaran- 
teed by a PID controller (Watlow, USA). The tempera- 
ture inside the cylinder is measured by a J-type thermo- 
couple with an accuracy of ±0.1˚C. Pressure is measured 
by a digital gauge manometer (Parker, USA). A specific 
amount of domperidone was weighed with an analytical 
balance (Shimadzu, Japan) having repeatability < 0.1 mg 
and put at the bottom of the cell. The cell was closed and 
heated to the set-up temperature. Then, CO2 preheated to 
the same temperature was pumped in the cell up to the 
final pressure by means of a manual piston pump (P1). 
The system was stored for 15 min under mechanical stir- 
ring to ensure that DMP were dissolved. 
Starting from this condition, the cell volume was gen- 
tly changed until cloud point was observed. 
Cloud point indicates the formation of solid phase 
from the solution. The pressure at which cloud point was 
observed is assumed as solubility point. 
2.3. Adsorption Experiments 
Adsorption isotherms were obtained using a static method 
described elsewhere [15]. The main part of the plant is an 
autoclave, consisting of a stainless steel cylinder having 
an internal volume of 100 mL. The autoclave was loaded 
with accurately weighed amounts of SA (about 0.25 g) 
cubic monoliths wrapped in filter paper in order to pre-  
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Figure 1. Experimental set-up for the measurement of the solubility of drugs in SC-CO2. 
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vent their contact with the solid domperidone placed on 
the bottom of the autoclave. A weighed amount of the 
drug was placed in a small container opened on the top to 
allow contact with CO2 and mounted axially on the im- 
peller shaft. The autoclave was closed, heated to the 
fixed temperature and, then, CO2 was slowly added to the 
system at constant flow rate of 10 mL/min. The amount 
of CO2 in the autoclave was calculated from the density 
data. When the working pressure was reached, the sys- 
tem was stored for a fixed time. Then, CO2 was vented 
out at a constant pressure drop of about 0.1 MPa/min. 
After the vessel was cooled, the impregnated SA was 
removed and weighed. The amount of adsorbed com-
pound was determined by the weight change of the SA 
using an analytical balance. The thermodynamics of ad- 
sorption was quantified by an adsorption isotherm, which 
relates to the concentration of the adsorbate in the SC- 
CO2 phase to the concentration of the adsorbate in the 
solid phase. Adsorption isotherms were obtained at 35˚C/ 
23.0MPa and 45˚C/23.0MPa. Adsorption experiments 
were repeated three times. The difference was less than 
5% between experiments probably due to loss of material 
by entrainment during depressurization through the filter 
paper, and to the deposition of non-adsorbed material on 
the surface of SA. 
2.4. Drug Dissolution Rate Analysis 
Domperidone dissolution profiles were obtained with a 
USP apparatus 2, consisting of Varian 7025, paddle dis-
solution tester (Varian, Agilent Technologies Italia s.p.a, 
Italy). All studies were run according to the USP 25 pad-
dle method: 150 rpm, 900 mL of dissolution medium, T 
= 37.2˚C ± 0.1˚C, sink conditions. The adsorbed SA 
monoliths were coarsely crushed in a mortar and sus- 
pended in water. Then, the aqueous solution was con- 
tinuously pumped to a flow cell in a spectrophotometer 
and absorbance was recorded at 284 nm. 
Dissolution curves were studied with samples of SA 
equivalent to 10 mg of DMP in 900 mL of buffer solu- 
tion. Following the method of Nagarsenker et al. [2], two 
buffer solutions were used. A buffer solution at pH = 1.2 
and a buffer solution at pH = 6.8. The first solution repre-
sents the gastric fluid, the second solution represents the 
intestinal fluid. 
3. Results and Discussion 
The experimental work basically consisted in 1) study of 
the solubility of DMP in SC-CO2 to know the saturation 
conditions as a function of temperature and pressure; 2) 
study of adsorption isotherms to know the relationship 
between concentration of DMP in the fluid phase and in 
the solid phase at equilibrium; 3) in vitro drug release 
study. 
3.1. Solubility Measurements 
The knowledge of DMP solubility is necessary to prepare 
saturated liquid phase solution for adsorption experi-
ments. In literature, no solubility data of DMP in SC-CO2 
were found. 
The solubility of DMP in SC-CO2was measured at 
45˚C under different pressures. Experimental results are 
shown in Figure 2. In the pressure range 11.0 - 23.0 MPa, 
the DMP solubility varied from 15 × 10−6 to 110.3 × 10−6 
mole fraction (y). As expected, the solubility increased 
with pressure as a result of the increase in the density of 
CO2. A solubility of DMP in SC-CO2 of 121 × 10−6 mole 
fraction was also measured at 35˚C/23.0MPa. 
3.2. Isotherms of Adsorption 
The adsorption isotherms of DMP on SA were obtained 
at 35˚C and 45˚C and 23.0 MPa. These conditions have 
been selected because they correspond to the maximum 
solubility of DMP in SC-CO2measured in this study. To 
ensure that equilibrium was reached, the adsorption pro- 
cess was carried out for a period of 24 h. The corre- 
sponding isotherm curves are presented in Figure 3 
where the DMP loading is reported as qe (mmol of DMP 
/grams of silica aerogel) and the solution concentration is 
expressed as C0 (mmol of DMP/liter of CO2). 
Obviously, the concentration of DMP on SA increases 
with increasing concentration of DMP in CO2; the 
maximum loading obtained is 0.035 mmolDMP/gSA that 
corresponds to 1.5 wt% of DMP with respect to SA. 
Thus, in 1 g of SA can be adsorbed 15 mg of DMP. Be-
cause the conventional therapeutic dose of DMP is 10 mg, 
it should be possible to prepare a 0.66 g SA tablet con-
taining the therapeutic dose of DMP. 
Brunauer et al. [18] classified the isotherms that are 
 
 
Figure 2. Solubility of DMP in SC-CO2 as a function of 
pressure. Solubility is expressed as molar fraction (y). 
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Figure 3. Adsorption isotherm for domperidone on silica 
aerogel at 35˚C/23.0MPa and 45˚C/23.0MPa. 
 
convex upward throughout (type I) as “favorable” to up- 
take of solute, whereas the ones that are concave upward 
throughout (type III) as “unfavorable” to uptake of solute. 
According to this classification, the isotherms obtained at 
35˚C and 45˚C are favorable. 
The Langmuir adsorption isotherm is most widely 
used for the sorption of organic compound from liquid 
and gaseous solutions. The model is based on several 
basic assumptions: a) sorption takes place on specificho- 
mogeneous sites within the adsorbent; b) a molecule oc- 
cupies a site; c) the adsorbent has a finite capacity for the 
adsorbate (at equilibrium, a saturation point is reached 
and further adsorption can proceed); d) all sites are iden- 
tical and energetically equivalent (adsorbents are struc- 
turally homogeneous). The linear form of the Langmuir 
equation is represented as follows: 
max
Ce
qe q max
1 e
L
C
K q
   
where qmax is the maximum capacity of adsorbate to form 
a complete monolayer on the surface (mmolDMP/ gSA), 
KL is the Langmuir constant related to the heat of adsorp-
tion. By plotting Ce/qe versus Ce, it is possible to obtain 
the value of qmax and KL from the slope and the intercept. 
The Langmuir isotherm model for DMP on SA are found 
to be linear over the whole concentration range studied 
with correlation coefficient R2 = 0.989. These high cor-
relation coefficient values strongly support the fact that 
the adsorption closely follows the Langmuir model of 
adsorption in both examined cases. The parameters found 
were qmax = 0.032 mmolDMP/gSA and KL = 69.44 for the 
isotherm at 45˚C; qmax = 0.036 mmolDMP/gSA and KL = 
194.79 for the isotherm at 35˚C. 
Large KL constant indicates a good affinity of adsorb- 
ents for the adsorbate resulting in a stable adsorption 
product. Thus, there is much stronger binding of DMP to 
SA at 35˚C. 
3.3. Dissolution Test 
We studied the dissolution rate of the drug in vitro. Wa- 
ter solution at pH = 1.2 and pH 6.8 were chosen as dis- 
solution media following the recommendation US Phar- 
macopeia. The dissolution profiles of the drug from the 
powdered loaded aerogel were compared with that of 
commercial DMP tablets. Release kinetics are shown in 
Figure 4. In the buffer at pH = 1.2 the dissolution of 
DMP from loaded aerogel is faster than dissolution of 
DMP-tablets. 65% of DMP dissolves from the aerogel 
within 15 minutes, whereas dissolving 65% of the crys- 
talline drug takes 30 min. 90% of DMP dissolves after 2 h  
 
 
 
Figure 4. Release kinetics of DMP-tablets (commercial 
DMP) and DMP adsorbed on silica aerogel in buffer solu-
tion at pH = 1.2 (left) and pH = 6.8 (right). Dissolution 
curves were obtained from samples equivalent to 10 mg of 
DMP in 900 mL of buffer solution. 
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in both cases. 
In the buffer at pH = 6.8 representing the intestinal 
fluid, a lower solubility of DMP was expected. Indeed, 
7% of DMP dissolves from tabletwithin one hour and 
than the concentration increases up to 11.5% within 8 
hours. DMP-SA has a much faster dissolution rate. 22% 
of DMP dissolves within one hour and 62% dissolves 
within 8 hours. These results are in good agreement with 
data reported by Nagarsenker et al. [2]. 
Thus, the use of hydrophilic aerogels as a carrier pro- 
motes fast release of the drug both at pH 1.2 and 6.8 with 
a marked gain in the latter case. This effect can be ex- 
plained by both an increase of specific surface area of the 
drug adsorbed on the aerogel and its non-crystalline 
structure in this state. In the case of the crystalline drug, 
even with a very small particle size, the crystal should be 
destroyed before the drug can be actually dissolved. If 
the drug is adsorbed on the aerogel, this step is elimi- 
nated and the dissolution process is accelerated. Another 
important effect is the partial collapse of aerogel struc- 
ture in water. Hydrophilic aerogels are rapidly wetted 
with water, so the drug molecules are surrounded with 
water allowing a fast dissolution of drugs [12]. 
4. Conclusion 
In this study, it was demonstrated that the supercritical 
fluid adsorption is an effective way to incorporate dom- 
peridone into a microporous silica aerogel. This tech- 
nique allows to obtain ultra pure drug delivery systems 
avoiding the use of organic solvents. Particularly, super- 
critical adsorption is suitable to generate domperidone/ 
SA composites for the fast release of domperidone. It is 
possible to prepare a 0.66 g SA tablet containing 10 mg 
therapeutic dose of domperidone with an enhanced drug 
release rate both in the gastric and intestinal fluid. The 
enhanced dissolution rate can be explained by both the 
increase in the specific surface area of the adsorbed drug 
and its non-crystalline structure in the formulation. The 
adsorption isotherms can be fitted to a Langmuir iso- 
therm model confirming the monolayer adsorption of 
DMP on SA, with the maximum monolayer adsorption 
capacities of 0.036 mmolDMP/gSA at 35˚C and 0.032 
mmolDMP/gSA at 45˚C. These results encourage the de-
velopment of industrial application of the proposed pro- 
cess. 
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